Does aging reduce naive B-cell diversity and weaken class-switched, high-affinity antibody responses?

Aging is associated with measurable remodeling of the B-cell compartment, relevant to responses against new antigens and to vaccination in later life. The evidence is stronger for loss of naïve repertoire breadth and reduced antibody-response magnitude than for a universal loss of antibody affinity.

Naïve B-cell repertoire

• Human immunoglobulin heavy-chain sequencing directly supports a narrower naïve B-cell receptor repertoire in older adults. In one study of 10 younger and 10 older healthy participants assessed around influenza vaccination, older adults had lower estimated repertoire diversity, fewer B-cell lineages, less within-lineage diversification, and a contracted naïve compartment.
• Aging is also associated with fewer circulating naïve B cells. This reduced cell abundance is distinct from, but consistent with, reduced clonal diversity and may limit the range of novel epitopes that can be recognized.

Antibody-response magnitude and quality

• Older age is consistently associated with lower vaccine-induced antibody concentrations and neutralizing titres, indicating weaker overall antigen-specific—typically class-switched—responses.
• Evidence that antibodies are uniformly lower-affinity or lower-avidity is less definitive. Some studies find preserved avidity or neutralizing activity relative to antigen-specific IgG, particularly where pre-existing memory B cells influence responses to familiar antigens.

Mechanistic context

• Reduced germinal-centre activity, diminished activation-induced cytidine deaminase (AID)-dependent class-switch recombination and somatic hypermutation, and impaired T-follicular-helper-cell support provide a biologically coherent explanation for weaker generation of switched, affinity-matured plasma cells and memory cells.
• In aged animal models, altered T-follicular-helper localization accompanies fewer affinity-enhancing mutations and fewer high-affinity plasma cells after immunization.

Bottom line

• Aging is supported by human data to reduce naïve B-cell repertoire diversity and is plausibly associated with weaker class-switched, affinity-matured responses. In practice, the most consistent consequence is lower antibody and neutralizing-titre magnitude; whether antibody affinity itself declines depends on antigen, vaccine platform, and prior immune memory.